home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Dietary Supplement Regulatory Compliance in the United States: Labeling, Product Claims & Updates from the FDA - Webinar By GlobalCompliancePanel

 
  January 05, 2012  
     
 
GlobalCompliancePanel, Online Training
2012-02-22


 This 90 minute live, interactive webinar will review the dietary supplement regulations and discuss how to verify that your products are compliant, while citing differences with food and drug regulations. We will also cover what qualifies a material as a dietary ingredient, considerations for manufacturers and distributors, requirements for compliant labeling and acceptable marketing claims. An update on FDA’s draft guidance for New Dietary Ingredients and an overview of the Dietary Supplement Labeling Act (both introduced in 2011) will also be discussed. At the conclusion of this 75 minute presentation, there will be a 15 minute Q&A session with the speaker. 

The FDA, with assistance from the FTC, has become increasingly aware of the large amount of dietary supplements that have come onto the market since the passage of the Dietary Supplement Health and Education Act in 1994. A growing public demand for supplements, along with a relatively relaxed pre-market approval process, has resulted in a flurry of companies creating and marketing their own dietary supplements in the United States.  With FDA beginning to take a stronger stance on Dietary Supplement enforcement, it is important for companies to verify that their products comply with the latest regulations and provisions.
Areas Covered In the Session:
  • Dietary Supplement Overview
    • What is a dietary supplement?
    • Supplements vs. Pharmaceuticals/OTC Drugs/Conventional Foods
  • Regulatory Structure
    • FDA Structure regarding Dietary Supplements
    • Industry Groups
  • History of Dietary Supplement Regulation
    • Early History & DSHEA
    • Code of Federal Regulations
  • Manufacturing Considerations
    • Company & Facility Registration
    • GMP Requirements
  • Dietary Ingredients
    • What qualifies as a dietary ingredient?
    • Old dietary ingredients vs. New dietary ingredients
    • New Dietary Ingredient Notification (NDIN)
    • Updated New Dietary Ingredient Guidance from FDA
  • Labeling Considerations
    • Display Panels & Layout
    • Supplement Facts Panel Requirements
    • Labeling Claims
      • Health vs. Disease vs. Structure/Function claims
      • Disclaimers/Substantiation
    • Notification of labeling claims to FDA
    • Dietary Supplement Labeling Act
  • Advertising Considerations
    • FDA vs. FTC jurisdiction & enforcement
    • Expressed vs. Implied Claims
    • Disclosures & Claim Substantiation
    • Testimonials
  • Questions & Answers
Who will benefit:
  • Executives of Dietary Supplement companies
  • Regulatory Compliance Professionals
  • Quality Assurance Professionals
  • Dietary Supplement Manufacturers
  • Dietary Supplement Distributors
  • Sales/Marketing Personnel
Price List:
Live : $245.00
Corporate live : $995.00
Recorded : $295.00
 
 
Organized by: GlobalCompliancePanel
Invited Speakers:
For the past 9 years, Bob has been President of RJR Consulting, Inc. The company assists the pharmaceutical, medical device and biotech industries in understanding and complying with International Regulations affecting compliance, new product development, manufacturing and quality assurance. RJR has offices in Columbus, OH, Washington, DC, Brussels, Belgium with exclusive affiliates across Asia and Latin America. Bob has 28 years of past industry experience as a CMC specialist, R&D Director and Global Director of Regulatory Affairs for Merion Merrill Dow pharmaceuticals and Cordis-Dow medical devices. He has a BS / MS degree in Chemistry.
 
Deadline for Abstracts: 2012-21-02
 
Registration:
Online Training

webinars@globalcompliancepanel.com
http://www.globalcompliancepanel.com

Phone: 800-447-9407
Fax: 302-288-6884
E-mail: globalcompliancepanel@gmail.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.